Kewaunee Scientific Reports Mixed Q3 Results, Repays $23M Seller Notes, Boosts Operating Cash Flow
KEQU sits 17% above its 52-week low of $30.33.
Summary
Kewaunee Scientific reported a decline in Q3 net earnings but a significant increase in nine-month operating cash flow and successfully repaid $23.0 million in seller notes, improving its debt structure. The order backlog, however, decreased year-over-year.
Key Events · Earnings and Guidance · KEQU
-
Q3 Net Earnings Decline
Net earnings attributable to Kewaunee Scientific Corporation fell by 48.9% to $0.692 million ($0.23 diluted EPS) for the three months ended January 31, 2026, compared to $1.354 million ($0.45 diluted EPS) in the prior year period.
-
Strong Operating Cash Flow Growth
Net cash provided by operating activities for the nine months ended January 31, 2026, significantly increased to $13.173 million, up from $5.376 million in the comparable prior year period.
-
Substantial Seller Note Repayment
The company fully repaid $23.0 million in subordinated seller notes on December 4, 2025, funded by a new $10.0 million term loan and available revolving credit, significantly reducing total liabilities and long-term debt.
-
Decreased Order Backlog
The order backlog stood at $183.2 million as of January 31, 2026, a decrease from $221.6 million at January 31, 2025.
Analysis · KEQU · Industrial Applications And Services
Kewaunee Scientific reported a significant year-over-year decline in Q3 net earnings and diluted EPS, which is a negative signal. However, the company demonstrated strong operational cash generation for the nine-month period, more than doubling cash provided by operating activities. A key positive development is the full repayment of $23.0 million in subordinated seller notes, a substantial reduction in long-term debt, which was partially funded by a new $10.0 million term loan. This debt restructuring improves the company's financial flexibility and reduces interest expense. The declining order backlog, previously reported, remains a concern for future revenue growth, indicating potential headwinds despite the strategic benefits from the Nu Aire acquisition.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30.2% of the 2009 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, KEQU was trading at $35.34 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $101.3M. The 52-week trading range was $30.33 to $60.89. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.